Patents by Inventor Batya Plotkin

Batya Plotkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLYCOGEN SYNTHASE KINASE-3 INHIBITORS
    Publication number: 20160130303
    Abstract: Novel peptide inhibitors of GSK-3, compositions containing same and uses thereof are disclosed. The novel peptide inhibitors are substrate-competitive inhibitors and have an amino acid sequence designed so as to bind to a defined binding site subunit in GSK-3. Also disclosed are GSK-3 substrate competitive inhibitors which bind to the defined binding site subunit in the enzyme. Also disclosed are mutants of GSK-3 and uses thereof for identifying a putative GSK-3 substrate competitive inhibitor.
    Type: Application
    Filed: January 12, 2016
    Publication date: May 12, 2016
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Hagit Eldar-Finkelman, Avital Licht-Murava, Batya Plotkin
  • Glycogen synthase kinase-3 inhibitors
    Patent number: 9243034
    Abstract: Novel peptide inhibitors of GSK-3, compositions containing same and uses thereof are disclosed. The novel peptide inhibitors are substrate-competitive inhibitors and have an amino acid sequence designed so as to bind to a defined binding site subunit in GSK-3. Also disclosed are GSK-3 substrate competitive inhibitors which bind to the defined binding site subunit in the enzyme. Also disclosed are mutants of GSK-3 and uses thereof for identifying a putative GSK-3 substrate competitive inhibitor.
    Type: Grant
    Filed: January 26, 2012
    Date of Patent: January 26, 2016
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Hagit Eldar-Finkelman, Avital Licht-Murava, Batya Plotkin
  • GLYCOGEN SYNTHASE KINASE-3 INHIBITORS
    Publication number: 20130310303
    Abstract: Novel peptide inhibitors of GSK-3, compositions containing same and uses thereof are disclosed. The novel peptide inhibitors are substrate-competitive inhibitors and have an amino acid sequence designed so as to bind to a defined binding site subunit in GSK-3. Also disclosed are GSK-3 substrate competitive inhibitors which bind to the defined binding site subunit in the enzyme. Also disclosed are mutants of GSK-3 and uses thereof for identifying a putative GSK-3 substrate competitive inhibitor.
    Type: Application
    Filed: January 26, 2012
    Publication date: November 21, 2013
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Hagit Eldar-Finkelman, Avital Licht-Murava, Batya Plotkin